| Literature DB >> 26957205 |
Koichiro Mihara1, Rithwik Ramachandran1, Mahmoud Saifeddine1, Kristina K Hansen1, Bernard Renaux1, Danny Polley1, Stacy Gibson1, Christina Vanderboor1, Morley D Hollenberg2.
Abstract
Thrombin is known to signal to cells by cleaving/activating a G-protein-coupled family of proteinase-activated receptors (PARs). The signaling mechanism involves the proteolytic unmasking of an N-terminal receptor sequence that acts as a tethered receptor-activating ligand. To date, the recognized targets of thrombin cleavage and activation for signaling are PAR1 and PAR4, in which thrombin cleaves at a conserved target arginine to reveal a tethered ligand. PAR2, which like PAR1 is also cleaved at an N-terminal arginine to unmask its tethered ligand, is generally regarded as a target for trypsin but not for thrombin signaling. We now show that thrombin, at concentrations that can be achieved at sites of acute injury or in a tumor microenvironment, can directly activate PAR2 vasorelaxation and signaling, stimulating calcium and mitogen-activated protein kinase responses along with triggeringβ-arrestin recruitment. Thus, PAR2 can be added alongside PAR1 and PAR4 to the targets, whereby thrombin can affect tissue function.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26957205 DOI: 10.1124/mol.115.102723
Source DB: PubMed Journal: Mol Pharmacol ISSN: 0026-895X Impact factor: 4.436